AstraZeneca CEO Faces Critical Pay Vote Amid Shareholder Divisions

As AstraZeneca's annual meeting looms, shareholders are split on a proposed £18.7m pay deal for CEO Pascal Soriot, with debates intensifying over the competitiveness of UK executive compensation.